{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T08:53:40Z","timestamp":1790758420624,"version":"4.1.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2021,5,29]],"date-time":"2021-05-29T00:00:00Z","timestamp":1622246400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,5,29]],"date-time":"2021-05-29T00:00:00Z","timestamp":1622246400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Cardiol"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1007\/s00246-021-02652-8","type":"journal-article","created":{"date-parts":[[2021,5,29]],"date-time":"2021-05-29T03:41:07Z","timestamp":1622259667000},"page":"1640-1646","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Aspirin Use and Transcatheter Pulmonary Valve Replacement, the Need for Consistency"],"prefix":"10.1007","volume":"42","author":[{"given":"Kamel","family":"Shibbani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruchira","family":"Garg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan M.","family":"Zahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2545-1241","authenticated-orcid":false,"given":"Daniel","family":"Mclennan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,29]]},"reference":[{"key":"2652_CR1","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1016\/j.jcin.2019.03.037","volume":"12","author":"S Georgiev","year":"2019","unstructured":"Georgiev S, Ewert P, Tanase D, Hess J, Hager A, Cleuziou J, Meierhofer C, Eicken A (2019) A low residual pressure gradient yields excellent long-term outcome after percutaneous pulmonary valve implantation. JACC Cardiovasc Interv 12:1594\u20131603","journal-title":"JACC Cardiovasc Interv"},{"key":"2652_CR2","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.ijcard.2017.10.015","volume":"250","author":"NA Haas","year":"2018","unstructured":"Haas NA, Carere RG, Kretschmar O, Horlick E, Rodes-Cabau J, de Wolf D, Gewillig M, Mullen M, Lehner A, Deutsch C, Bramlage P, Ewert P (2018) Early outcomes of percutaneous pulmonary valve implantation using the Edwards SAPIEN XT transcatheter heart valve system. Int J Cardiol 250:86\u201391","journal-title":"Int J Cardiol"},{"key":"2652_CR3","doi-asserted-by":"publisher","first-page":"2248","DOI":"10.1016\/j.jacc.2011.07.040","volume":"58","author":"D Kenny","year":"2011","unstructured":"Kenny D, Hijazi ZM, Kar S, Rhodes J, Mullen M, Makkar R, Shirali G, Fogel M, Fahey J, Heitschmidt MG, Cain C (2011) Percutaneous implantation of the Edwards SAPIEN transcatheter heart valve for conduit failure in the pulmonary position: early phase 1 results from an international multicenter clinical trial. J Am Coll Cardiol 58:2248\u20132256","journal-title":"J Am Coll Cardiol"},{"key":"2652_CR4","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s40119-012-0005-9","volume":"1","author":"H Ghawi","year":"2012","unstructured":"Ghawi H, Kenny D, Hijazi ZM (2012) Transcatheter pulmonary valve replacement. Cardiol Ther 1:5","journal-title":"Cardiol Ther"},{"key":"2652_CR5","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1016\/j.jcin.2017.05.022","volume":"10","author":"AK Cabalka","year":"2017","unstructured":"Cabalka AK, Hellenbrand WE, Eicken A, Kreutzer J, Gray RG, Bergersen L, Berger F, Armstrong AK, Cheatham JP, Zahn EM, McElhinney DB (2017) Relationships among conduit type, pre-stenting, and outcomes in patients undergoing transcatheter pulmonary valve replacement in the prospective North American and European Melody Valve Trials. JACC Cardiovasc Interv 10:1746\u20131759","journal-title":"JACC Cardiovasc Interv"},{"key":"2652_CR6","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.acvd.2014.09.003","volume":"108","author":"Malekzadeh-Milania S, Ladouceura M, Patel M, Boughenoua FM, Iserin L, Bonne D, Boudjemline Y","year":"2015","unstructured":"Malekzadeh-Milania S, Ladouceura M, Patel M, Boughenoua FM, Iserin L, Bonne D, Boudjemline Y (2015) Incidence and predictors of Melody\u00ae valve endocarditis: a prospective study. Arch Cardiovasc Dis 108:97\u2013106","journal-title":"Arch Cardiovasc Dis"},{"key":"2652_CR7","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000923","author":"CM Otto","year":"2020","unstructured":"Otto CM, Nishimura RA, Bonow RO, Carabello BA, Erwin JP 3rd, Gentile F, Jneid H, Krieger EV, Mack M, McLeod C, O\u2019Gara PT, Rigolin VH, Sundt TM 3rd, Thompson A, Toly C (2020) 2020 ACC\/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. https:\/\/doi.org\/10.1161\/CIR.0000000000000923","journal-title":"Circulation"},{"key":"2652_CR8","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1161\/01.CIR.96.4.1109","volume":"96","author":"F Cipollone","year":"1997","unstructured":"Cipollone F, Patrignani P, Greco A, Rosaria Panara M, Padovano R, Cuccurullo F, Patrono C, Rebuzzi AG, Liuzzo G, Quaranta G, Maseri A (1997) Differential suppression of thromboxane biosynthesis by indobufen and aspirin in patients with unstable angina. Circulation 96:1109\u20131116","journal-title":"Circulation"},{"key":"2652_CR9","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1161\/01.CIR.0000134791.68010.FA","volume":"110","author":"EMAD Antman","year":"2004","unstructured":"Antman EMAD, Armstrong PW, Bates ER, Green LA, Hand M, Hochman JS, Krumholz HM, Kushner FG, Lamas GA, Mullany CJ, Ornato JP, Pearle DL, Sloan MA, Smith SC Jr (2004) ACC\/AHA guidelines for the management of patients with ST-elevation myocardial infarction. Circulation 110:588\u2013636","journal-title":"Circulation"},{"key":"2652_CR10","doi-asserted-by":"publisher","first-page":"e89S","DOI":"10.1378\/chest.11-2293","volume":"141","author":"JW Eikelboom","year":"2012","unstructured":"Eikelboom JW, Hirsh J, Spencer FA, Baglin TP, Weitz JI (2012) Antiplatelet drugs: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141:e89S-e119S","journal-title":"Chest"},{"key":"2652_CR11","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1136\/hrt.2009.181107","volume":"96","author":"M Wurtz","year":"2010","unstructured":"Wurtz M, Grove EL, Kristensen SD, Hvas AM (2010) The antiplatelet effect of aspirin is reduced by proton pump inhibitors in patients with coronary artery disease. Heart 96:368\u2013371","journal-title":"Heart"},{"key":"2652_CR12","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1111\/j.1365-2125.2011.03943.x","volume":"72","author":"TD Warner","year":"2011","unstructured":"Warner TD, Nylander S, Whatling C (2011) Anti-platelet therapy: cyclo-oxygenase inhibition and the use of aspirin with particular regard to dual anti-platelet therapy. Br J Clin Pharmacol 72:619\u2013633","journal-title":"Br J Clin Pharmacol"},{"key":"2652_CR13","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/j.1538-7836.2005.01119.x","volume":"3","author":"CL Campbell","year":"2005","unstructured":"Campbell CL, Steinhubl SR (2005) Variability in response to aspirin\u2014do we understand the clinical relevance. J Thromb Hemost 3:5","journal-title":"J Thromb Hemost"},{"key":"2652_CR14","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/S0140-6736(10)61001-X","volume":"376","author":"Mehta SR, Tanguay JF, Eikelboom JW, Jolly SS, Joyner CD, Granger CB, Faxon DP, Rupprecht HJ, Budaj A, Avezum A, Widimsky P, Steg PG, Bassand JP, Montalescot G, Macaya C, Pasquale GD, Niemela K, Ajani AE, White HD, Chrolavicius S, Gao P, Fox KAA, YusuF S","year":"2010","unstructured":"Mehta SR, Tanguay JF, Eikelboom JW, Jolly SS, Joyner CD, Granger CB, Faxon DP, Rupprecht HJ, Budaj A, Avezum A, Widimsky P, Steg PG, Bassand JP, Montalescot G, Macaya C, Pasquale GD, Niemela K, Ajani AE, White HD, Chrolavicius S, Gao P, Fox KAA, YusuF S (2010) Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial. The Lancet 376:10","journal-title":"The Lancet"},{"key":"2652_CR15","doi-asserted-by":"publisher","first-page":"44","DOI":"10.3389\/fcvm.2019.00044","volume":"6","author":"L Rosseel","year":"2019","unstructured":"Rosseel L, De Backer O, Sondergaard L (2019) Clinical valve thrombosis and subclinical leaflet thrombosis following transcatheter aortic valve replacement: is there a need for a patient-tailored antithrombotic therapy? Front Cardiovasc Med 6:44","journal-title":"Front Cardiovasc Med"},{"key":"2652_CR16","doi-asserted-by":"publisher","first-page":"3156","DOI":"10.1161\/CIRCULATIONAHA.106.675587","volume":"115","author":"PA Gurbel","year":"2007","unstructured":"Gurbel PA, Bliden KP, DiChiara J, Newcomer J, Weng W, Neerchal NK, Gesheff T, Chaganti SK, Etherington A, Tantry US (2007) Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study. Circulation 115:3156\u20133164","journal-title":"Circulation"},{"key":"2652_CR17","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1111\/j.1755-5922.2010.00188.x","volume":"29","author":"J Dawson","year":"2011","unstructured":"Dawson J, Quinn T, Rafferty M, Higgins P, Ray G, Lees KR, Walters MR (2011) Aspirin resistance and compliance with therapy. Cardiovasc Ther 29:301\u2013307","journal-title":"Cardiovasc Ther"},{"key":"2652_CR18","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/1479-5876-6-47","volume":"6","author":"E Shantsila","year":"2008","unstructured":"Shantsila E, Lip GY (2008) \u201cAspirin resistance\u201d or treatment non-compliance: which is to blame for cardiovascular complications? J Transl Med 6:47","journal-title":"J Transl Med"},{"key":"2652_CR19","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/1479-5876-6-46","volume":"6","author":"KA Schwartz","year":"2008","unstructured":"Schwartz KA, Schwartz DE, Barber K, Reeves M, De Franco AC (2008) Non-compliance is the predominant cause of aspirin resistance in chronic coronary arterial disease patients. J Transl Med 6:46","journal-title":"J Transl Med"}],"container-title":["Pediatric Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00246-021-02652-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00246-021-02652-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00246-021-02652-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,24]],"date-time":"2021-09-24T20:11:01Z","timestamp":1632514261000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00246-021-02652-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,29]]},"references-count":19,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["2652"],"URL":"https:\/\/doi.org\/10.1007\/s00246-021-02652-8","relation":{},"ISSN":["0172-0643","1432-1971"],"issn-type":[{"value":"0172-0643","type":"print"},{"value":"1432-1971","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,29]]},"assertion":[{"value":"10 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Evan Zahn is a proctor, a consultant and a former site Principle Investigator for Medtronic. Evan Zahn is a proctor, a consultant, and a national Principle Investigator for Edwards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}